Common early-life exposure of the colorectal epithelium to the microbiome-derived mutagen colibactin
Colibactin is a mutagen produced by bacterial strains in the colorectal microbiomes of some healthy people. It generates somatic mutations characterised by the mutational signatures SBS88 and ID18 in normal human colorectal epithelial cells in vivo. Increasing prevalence of colibactin mutagenesis during the 20th century is hypothesised to have caused recent international increases in early-onset colorectal cancer incidence. Here, we establish the early-life prevalence, timing, mutation burdens and distribution through the colon of colibactin mutagenesis by sequencing normal colorectal epithelial cell genomes to detect SBS88 and ID18 in 90 healthy and inflammatory bowel disease affected children and adolescents. Colibactin-induced mutagenesis was present in ~43%, with or without inflammatory bowel disease. It usually begins shortly after birth and ceases by age five years. Mutation burdens are higher in the left than right colon and show substantial variation, with some children displaying mutation burdens comparable to those of healthy non-exposed individuals greater than 60 years of age. The future public health implications of this common early life mutagen exposure will depend on clarification of its role in colorectal cancer causation.
Authors
- Paul Brennan (ORCID: https://orcid.org/0000-0002-0518-8714)
- Claire Glemas
- Johan M. Burisch (ORCID: https://orcid.org/0000-0002-3312-5139)
- Nicolas Wyvekens (ORCID: https://orcid.org/0000-0002-8702-7091)
- Laura Humphreys (ORCID: https://orcid.org/0009-0008-6697-8091)
- Kelly Spike
- Matthias Zilbauer (ORCID: https://orcid.org/0000-0002-7272-0547)
- Raheleh Rahbari (ORCID: https://orcid.org/0000-0002-1839-7785)
- Yan Shao (ORCID: https://orcid.org/0000-0002-8662-0504)
- Maria Dorn‐Rasmussen (ORCID: https://orcid.org/0000-0003-4960-3606)
- My H. Pham (ORCID: https://orcid.org/0000-0002-0074-0733)
- Henry N. Marshall (ORCID: https://orcid.org/0000-0002-4425-2272)
- Trevor D. Lawley (ORCID: https://orcid.org/0000-0002-4805-621X)
- Will Knight
- Ammal Abbasi (ORCID: https://orcid.org/0000-0003-0623-2243)
- Vibeke Wewer (ORCID: https://orcid.org/0000-0001-9116-9458)
- Stephen F. Fitzgerald (ORCID: https://orcid.org/0000-0001-5025-3733)
- Anh Phuong Le (ORCID: https://orcid.org/0000-0002-0477-9969)
- Michael R. Stratton (ORCID: https://orcid.org/0000-0001-6035-153X)
- Tim H. H. Coorens (ORCID: https://orcid.org/0000-0002-5826-3554)
- Komal Nayak
- Ievgeniia Chicherova (ORCID: https://orcid.org/0000-0002-0764-9641)
- Yichen Wang (ORCID: https://orcid.org/0000-0001-5122-7545)
- Yvette E. Hooks
- Ludmil B. Alexandrov (ORCID: https://orcid.org/0000-0003-3596-4515)
- Rashesh Sanghvi (ORCID: https://orcid.org/0000-0002-7703-9216)
- Andrew Ramos
- Calli Latimer (ORCID: https://orcid.org/0009-0009-5393-808X)
- Sarah Moody (ORCID: https://orcid.org/0000-0003-4904-1041)
- Inigo Martincorena
- Soyeon Kim (ORCID: https://orcid.org/0009-0004-6509-5490)
- Peter Campbell
- Jiali Pang
- Rob Heuschkel
- Hyunchul Jung
Institutions
- Broad Institute (US)
- European Bioinformatics Institute (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- University of Cambridge (GB)
- Amager Hospital (DK)
- Hvidovre Hospital (DK)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Wellcome Sanger Institute (GB)
- Copenhagen University Hospital (DK)
- University of California San Diego (US)
- Bridge University (SS)
- Centre international de recherche sur le cancer (FR)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.64898/2026.11.16.766949
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- preprint
Funders
- Wellcome Trust
- Novo Nordisk
- HORIZON EUROPE Framework Programme